G1733A (RS6152) polymorphism of the androgen receptor gene in patients with prostate cancer

Journal Title: UNKNOWN - Year 2018, Vol 1, Issue 4

Abstract

Aim: The causes of prostate cancer development and molecular mechanism underlying its development and progression are not clearly understood. The aim of this study is to determine the frequency of G1733A (rs6152) polymorphism of the androgen receptor (AR) gene among patients with prostate cancer, and to examine the role of this polymorphism in the development of prostate cancer. Method: DNA samples isolated from 96 individuals (49 patients with prostate cancer and 47 controls) were analyzed with real time-polymerase chain reaction (real time-PCR) in order to determine G1733A (rs6152) polymorphism genotypes and allele frequencies in the AR gene. The results were evaluated statistically. Results: Genotype frequency was determined as 91% GG and 9% AG among the controls, and 67% GG and 33% AG among the patients. G allele frequency was 95% in controls and 83% in patients, whereas A allele frequency was 5% in controls and 17% in patients. There was a statistically significant difference between patient and control groups regarding genotype frequency (p<0.05). Conclusion: Based on the results of our study, we can infer that G1733A (rs6152) polymorphism of the AR gene plays a role in development of prostate cancer in the Turkish population.

Authors and Affiliations

Omer Faruk Yagli, Serkan Ozcan, Tolga Karakan, Ali Osman Arslan, Ali Akkoc, Selma Duzenli, Ahmet Metin

Keywords

Related Articles

Patients’ misperception regarding the difficulty of lumbar puncture

Aim: Lumbar puncture (LP) is a crucial method of diagnosis and treatment of neurological diseases. Despite its importance, the patients' refusal of the procedure leads to difficulties in diagnosis and treatment. One of t...

The role of performing a routine four-quadrant cervical biopsy in patients with negative colposcopic findings in increasing the identification rate of cervical intraepithelial neoplasms

Aim: In patients with high-risk human papilloma virus (HPV), there is no consensus on the inclusion of cervical biopsy for diagnostic purposes in cases whereas there is no pathological finding in colposcopy. In this stud...

Does hemogram biomarkers predict mortality in intensive care population?

Aim: To compare hemogram-mediated inflammatory markers such as mean platelet volume (MPV), red cell distribution width (RDW), platelet distribution width (PDW), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyt...

Evaluation of retinal nerve fiber layer and ganglion cell layer thicknesses with optical coherence tomography in patients with vitamin B12 deficiency

Aim: We aimed to compare the retinal nerve fiber layer (RNFL) and ganglion cell layer (GCL) thickness of B12 vitamin deficiency patients with healthy controls using optical coherence tomography (OCT). Methods:...

Thyroid fine needle aspiration reporting rates and outcomes before and after Bethesda implementation: A single-center experience over 8 years

Aimː To evaluate data from our hospital system before and after the implementation of the Bethesda System for Reporting Thyroid Cytology (TBSRTC) and comparison of our data with the previously published studies. Methods:...

Download PDF file
  • EP ID EP489336
  • DOI 10.30714/j-ebr.2018443415
  • Views 145
  • Downloads 0

How To Cite

Omer Faruk Yagli, Serkan Ozcan, Tolga Karakan, Ali Osman Arslan, Ali Akkoc, Selma Duzenli, Ahmet Metin (2018). G1733A (RS6152) polymorphism of the androgen receptor gene in patients with prostate cancer. UNKNOWN, 1(4), 128-134. https://europub.co.uk/articles/-A-489336